Ocrelizumab-Induced Severe Colitis
We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.
Saved in:
Main Authors: | Hsing Hwa Lee, Naveen Sritharan, Daniel Bermingham, Gabriela Strey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/8858378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ocrelizumab-induced colitis—critical review and case series from a Romanian cohort of MS patients
by: Ileana Maria Vodă, et al.
Published: (2025-02-01) -
Evolution of Collagenous Colitis into Severe and Extensive Ulcerative Colitis
by: Hugh J Freeman, et al.
Published: (2007-01-01) -
Colonic cytokines for severe ulcerative colitis
by: Ye. A. Konovich, et al.
Published: (2016-08-01) -
Stress induced experimental colitis
by: T. A. Stein, et al.
Published: (1993-01-01) -
Sulphasalazine-Induced Pseudomembranous Colitis
by: Hugh J Freeman, et al.
Published: (1991-01-01)